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Abstract Lectin-like oxidized lipoprotein receptor-1 (LOX-1)
is a specific receptor for atherogenic oxidized low density
lipoprotein (OxLDL) which belongs to the scavenger receptor
family. In the present report, we show that LOX-1 can also
support cell adhesion to fibronectin (FN) in a divalent cation-
independent fashion. CHO-K1 cells stably expressing bovine
LOX-1 (BLOX-1-CHO), but not untransfected CHO-K1 cells,
can adhere to FN-coated plates, but not to collagen-coated
plates, in the presence of EDTA. BLOX-1-CHO adhesion to
FN-coated plates can also be suppressed by scavenger receptor
ligands, such as OxLDL, polyinosinic acid (poly I), and dextran
sulfate, but not by native LDL, acetylated LDL, polycytidylic
acid (poly C), or chondroitin sulfate. Cultured bovine aortic
endothelial cells can similarly adhere to FN-coated plates, which
was inhibited by OxLDL, poly I, and dextran sulfate in the
presence of EDTA. LOX-1 may play an important role in cell
adhesion to FN in an integrin-independent manner. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Cell adhesion to extracellular matrix (ECM) proteins, such
as ¢bronectin (FN), laminin, and collagen, appears to be in-
volved in cell migration and maintenance of cellular functions.
Integrins, including KvL3 integrin, are known to play key
roles in adhesion between cells and ECM in a divalent cat-
ion-dependent manner, recognizing RGDS sequence in the
ECM proteins [1]. Other molecules, however, may also be
involved in cell^ECM interactions.
Lectin-like oxidized low density lipoprotein receptor-1
(LOX-1) is a type II membrane glycoprotein, belonging to
the scavenger receptor family molecules, which was initially
cloned in cultured bovine aortic endothelial cells (BAEC) [2^
4]. Like other scavenger receptors, LOX-1 has a wide spec-
trum of pathophysiological ligands, including oxidized low
density lipoprotein (OxLDL) [5], aged/apoptotic cells [6], ac-
tivated platelets [7], and bacteria [8]. LOX-1 expression can be
dynamically modulated by a variety of biological stimuli, such
as tumor necrosis factor-K [9], transforming growth factor-L
[10], angiotensin II [11,12], OxLDL [13^15], and £uid shear
stress [13]. LOX-1 expression is not con¢ned to vascular en-
dothelial cells, but macrophages [16,17] and vascular smooth
muscle cell [10,18^20] can express this molecule. More impor-
tantly, LOX-1 is highly expressed by these cell types in ath-
erosclerotic lesions of humans and rabbits at the various
stages in vivo [21,22].
Some of the scavenger receptors, such as macrophage class
A scavenger receptors [23^25] and CD36 [26^28], can adhere
to ECM proteins, including type I collagen and thrombospon-
din. Therefore, we sought to determine if LOX-1 can bind
certain ECM proteins. In the present study, we show that
LOX-1 can selectively adhere to FN in a mechanism inde-
pendent of divalent cations and integrins.
2. Materials and methods
2.1. Reagents
Dulbecco’s modi¢ed Eagle medium (DMEM), and Ham’s F12 me-
dium were obtained from Nissui (Tokyo, Japan). Fetal calf serum
(FCS) was purchased from Sanko Junyaku (Tokyo, Japan). Polyino-
sinic acid (poly I), polycytidylic acid (poly C), dextran sulfate, chon-
droitin sulfate and RGDS were from Sigma (St. Louis, MO, USA).
LDL was isolated from human plasma by sequential ultracentrifuga-
tion, and oxidative modi¢cation of LDL was carried out in vitro by
cupric ion as previously described [2,5].
2.2. Cell culture
BAEC were isolated from bovine aortas by scraping the inner sur-
face with sterile glass coverslips, and cultured in DMEM containing
10% heat-inactivated FCS in an atmosphere of 95% air, 5% CO2 at
37‡C. Wild-type CHO-K1 cells were maintained in F12/10% FCS.
CHO-K1 cells stably expressing bovine LOX-1 (BLOX-1-CHO)
were maintained in F12/10% FCS supplemented with 10 Wg/ml of
blasticidin S (Funakoshi) as previously described [2,5].
2.3. Adhesion assay
Cells were detached from culture plates by incubation with culture
medium containing 5 mM EDTA at 37‡C for 5 min. For adhesion
assay, cells were washed twice, suspended in culture medium with or
without 5 mM EDTA at the cell density of 1U105 cells/ml, loaded
onto 35 mm plates coated with bovine FN or type I collagen (Iwaki,
Tokyo, Japan), which had been preincubated with the same media
alone (without cells) for 15 min, and incubated at 37‡C for 30 min
to allow the loaded cells to adhere. Tissue culture plates without coat-
ing served as negative controls. In some experiments, adhesion assay
was performed in the presence or absence of scavenger receptor li-
gands or an integrin ligand, RGDS. These reagents were preincubated
with cells for 15 min before cells were loaded onto the assay plates,
and used at concentrations of 50 Wg/ml for native LDL and OxLDL,
200 Wg/ml for dextran sulfate and chondroitin sulfate, 100 Wg/ml for
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poly I and poly C, and 1 mM for RGDS. Unbound cells were re-
moved by washing three times with the assay medium. Numbers of
cells adherent to FN-coated plates were counted under phase-contrast
microscopy. For each well, the mean adherent cell number was calcu-
lated by counting adherent cells in three di¡erent microscopic ¢elds
under phase-contrast microscopy. All the experiments were performed
in triplicate.
3. Results
3.1. Divalent cation-independent adhesion of BAEC to FN
Although most of BAEC adhesion to FN appears to de-
pend upon divalent cations, approximately one ¢fth of BAEC
adhesion to FN appears EDTA-insensitive (Fig. 1). This
EDTA-resistant binding to FN was inhibited by OxLDL,
but not by native LDL (Fig. 2), as well as scavenger receptor
ligands, such as poly I and dextran sulfate, but not by poly C
or chondroitin sulfate (Fig. 3). RGDS peptide, which blocks
integrin-dependent adhesion to FN, did not suppress EDTA-
resistant adhesion of BAEC to FN (Fig. 3). These results thus
suggest that certain scavenger receptors, but not integrins,
may be involved in EDTA-resistant cells adhesion to FN.
3.2. Divalent cation-independent adhesion of LOX-1 to FN
To explore the involvement of LOX-1 in divalent cation-
independent cell adhesion to FN, we examined whether
BLOX-1-CHO can adhere to FN-coated plates in the presence
of EDTA. In the absence of EDTA, both BLOX-1-CHO and
untransfected CHO-K1 cells were equally bound to FN-
coated plates, probably depending upon integrin^FN interac-
tions (Fig. 4). In the presence of EDTA, in contrast, BLOX-1-
CHO, but not untransfected CHO-K1 cells, were bound to
FN-coated plates, although the adherent cell numbers were
reduced when compared to those without EDTA (Fig. 4).
Fig. 1. Divalent cation-dependent and -independent adhesion of
BAEC to FN-coated plates. BAEC, which are suspended in culture
media containing 10% FCS with or without 5 mM EDTA, were
loaded onto FN-coated culture plates. Numbers of cells adherent to
FN-coated plates were determined by visual counting under phase-
contrast microscopy. Values are means þ S.D. of three independent
experiments.
Fig. 2. Inhibition of BAEC adhesion to FN-coated plates by
OxLDL. BAEC in culture medium containing 5 mM EDTA and
10% FCS were loaded onto FN-coated plates in the absence (A) or
presence of OxLDL (B) or native LDL (C). Lipoproteins were pre-
incubated with BAEC for 15 min and used at a concentration of 50
Wg/ml. Representative photomicrographs are shown.
Fig. 3. Inhibition of BAEC adhesion to FN-coated plates by various
scavenger receptor ligands. BAEC in culture medium containing
5 mM EDTA and 10% FCS were loaded onto FN-coated plates in
the absence or presence of scavenger receptor ligands and the con-
trol compounds as indicated. Test reagents were preincubated with
BAEC for 15 min and used at concentrations of 200 Wg/ml for dex-
tran sulfate and chondroitin sulfate, 100 Wg/ml for poly I and poly
C, 1 mM for RGDS. Numbers of cells adherent to FN-coated
plates were counted under phase-contrast microscopy. Relative num-
bers of adherent cells are indicated. Values are means þ S.D. of
three independent experiments.
Fig. 4. Divalent cation-dependent and -independent adhesion of
BLOX-1-CHO to FN-coated plates. BLOX-1-CHO (black bars) and
untransfected CHO-K1 cells, which are suspended in culture media
containing 10% FCS with or without 5 mM EDTA, were loaded
onto FN-coated culture plates. Numbers of cells adherent to FN-
coated plates were determined by visual counting under phase-con-
trast microscopy. Values are means þ S.D. of three independent ex-
periments.
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CHO-K1 cells stably transfected with murine LOX-1 showed
similar results (data not shown). In addition, COS-7 cells ex-
pressing LOX-1 similarly adhered to plates coated with hu-
man FN (Becton-Dickinson, Bedford, MA, USA; data not
shown).
To examine whether serum factors are required in LOX-1^
FN adhesion, adhesion assays were carried out in the presence
or absence of FCS (Fig. 5). Adhesion of BLOX-1-CHO to
FN-coated plates was rather slightly enhanced in the absence
of FCS, suggesting that certain serum factors might rather
suppress LOX-1^FN adhesion (Fig. 5).
3.3. Scavenger receptor ligands inhibit LOX-1^FN interactions
Negligible numbers of cells were bound to the culture plates
without FN-coating (Fig. 6E) or type I collagen-coated plates
(Fig. 6F) when compared to FN-coated plates (Fig. 6B) in the
presence of EDTA. Untransfected CHO-K1 cells did not ad-
here to FN-coated plates (Fig. 6A). EDTA-resistant binding
of LOX-1 to FN can be suppressed by OxLDL (Fig. 6C) but
not by native LDL (Fig. 6D). Therefore, LOX-1^FN binding
appears speci¢c and FN and OxLDL share the same binding
sites on LOX-1.
Previous studies have shown that scavenger receptor li-
gands, such as poly I and dextran sulfate, inhibited the bind-
ing of OxLDL to BLOX-1-CHO cells. We, therefore, exam-
ined whether these scavenger receptor ligands can inhibit the
binding of LOX-1 to FN. As shown in Fig. 7, poly I and
dextran sulfate inhibited the binding of BLOX-1-CHO cells
to FN-coated plates. OxLDL also inhibited BLOX-1-CHO
cell adhesion to FN as shown in Fig. 3C. In contrast,
RGDS peptide, which is known to inhibit binding of integrins
to FN, failed to show any inhibitory e¡ects on LOX-1^FN
adhesion, indicating that this binding is independent of integ-
rins (Fig. 7). Neither poly C, chondroitin sulfate, nor native
LDL inhibited the LOX-1^FN binding, indicating the specif-
icity of the inhibitors (Fig. 7).
4. Discussion
Adhesion of vascular endothelial cells to ECM proteins
appears to be involved in various aspects of vascular functions
Fig. 5. Dependence upon serum factors in BLOX-1-CHO adhesion
to FN-coated plates. BLOX-1-CHO (black bars) and untransfected
CHO-K1 cells (white bars) suspended in culture medium containing
5 mM EDTA with or without 10% FCS were loaded onto FN-
coated culture plates. Numbers of cells adherent to FN-coated
plates were counted under phase-contrast microscopy. Values are
means þ S.D. of three independent experiments.
Fig. 6. Inhibition by OxLDL and various scavenger receptor ligands
in BLOX-1-CHO adhesion to FN-coated plates. BLOX-1-CHO cells
(B^F) suspended in culture medium containing 5 mM EDTA and
10% FCS were loaded onto FN-coated plates (A^D) in the absence
(A, B) or presence of OxLDL (C), native LDL (D). Lipoproteins
were preincubated for 15 min and used at a concentration of 50 Wg/
ml. Adhesion of untransfected CHO-K1 cells (A) to FN-coated
plates, adhesion of BLOX-1-CHO cells to uncoated (E) or type I
collagen-coated (F) plates served as negative controls. Photomicro-
graphs were taken under phase-contrast microscopy (A^F).
Fig. 7. Inhibitory e¡ects of scavenger receptor ligands on BLOX-1-
CHO adhesion to FN-coated plates. BLOX-1-CHO cells suspended
in culture medium containing 5 mM EDTA and 10% FCS were
loaded onto FN-coated plates in the presence or absence (none) of
poly I, poly C, dextran sulfate, chondroitin sulfate, OxLDL, native
LDL, or RGDS as indicated. Inhibitors were preincubated for 15
min and used at concentrations of 50 Wg/ml for native LDL and
OxLDL, 200 Wg/ml for dextran sulfate and chondroitin sulfate, 100
Wg/ml for poly I and poly C, and 1 mM for RGDS.
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including angiogenesis. Integrins have been shown to play key
roles in endothelial^ECM adhesion; however, the present
study demonstrated, for the ¢rst time, that LOX-1, a member
of the scavenger receptor family molecules, can support adhe-
sion to FN in a divalent cation-independent manner.
Binding of OxLDL to LOX-1 has been suppressed by scav-
enger receptor ligands, such as poly I and dextran sulfate [5].
As shown in this study, LOX-1 adhesion to FN was similarly
suppressed by poly I and dextran sulfate. Furthermore, LOX-
1^FN adhesion was inhibited by OxLDL. These results thus
indicate that FN and OxLDL, as well as poly I and dextran
sulfate, appear to share the common binding sites on the
LOX-1 molecule.
Interactions between cells and ECM proteins appear to af-
fect a variety of biological functions, including cell migration
and invasion. In the vascular system, endothelial^ECM adhe-
sion may play key roles in angiogenesis, in addition to ECM
degradation. Interestingly, angiogenesis can be potently in-
duced by hypoxia in vitro and in vivo, and LOX-1 expression
can be drastically induced by hypoxia [29]. In addition, our
previous studies with human atherosclerotic lesions revealed
that LOX-1 was highly expressed by neovascular endothelial
cells in the arterial intima [21]. These results suggest that hyp-
oxia-induced LOX-1 and its interactions with ECM may play
a role in the angiogenic processes, although this hypothesis
remains to be proved.
In addition to vascular endothelial cells, LOX-1 is also ex-
pressed by macrophages and activated vascular smooth
muscle cells ; therefore, LOX-1 adhesion to ECM proteins
might also be involved in migration and accumulation of these
cell types in various pathophysiological settings including
atherogenesis and in£ammatory responses, although the roles
of LOX-1 in vivo remain to be fully elucidated.
In summary, this report provides evidence, for the ¢rst
time, that LOX-1, a member of the scavenger receptor family,
can support cell adhesion to an ECM protein, FN. Further
studies related to the overexpression and functional blocking
of LOX-1 in a variety of pathophysiological settings in vivo
may provide new insights into the roles of LOX-1.
References
[1] Brooks, P.C., Montgomery, A.M., Rosenfeld, M., Reisfeld, R.A.,
Hu, T., Klier, G. and Cheresh, D.A. (1994) Cell 79, 1157^1164.
[2] Sawamura, T., Kume, N., Aoyama, T., Moriwaki, H., Hoshika-
wa, H., Aiba, Y., Tanaka, T., Miwa, S., Katsura, Y., Kita, T.
and Masaki, T. (1997) Nature 386, 73^77.
[3] Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Murase, T.,
Sawamura, T., Masaki, T., Hashimoto, N. and Kita, T. (2000)
J. Biol. Chem. 275, 6573^6579.
[4] Kita, T. (1999) Circ. Res. 84, 1113^1115.
[5] Moriwaki, H., Kume, N., Sawamura, T., Aoyama, T., Hoshika-
wa, H., Ochi, H., Nishi, E., Masaki, T. and Kita, T. (1998)
Arterioscler. Thromb. Vasc. Biol. 18, 1541^1547.
[6] Oka, K., Sawamura, T., Kikuta, K., Itokawa, S., Kume, N.,
Kita, T. and Masaki, T. (1998) Proc. Natl. Acad. Sci. USA 95,
9535^9540.
[7] Kakutani, M., Masaki, T. and Sawamura, T. (2000) Proc. Natl.
Acad. Sci. USA 97, 360^364.
[8] Shimaoka, T., Kume, N., Minami, M., Hayashida, K., Sawa-
mura, T., Kita, T. and Yonehara, S. (2001) J. Immunol. 166,
5108^5114.
[9] Kume, N., Murase, T., Moriwaki, H., Aoyama, T., Sawamura,
T., Masaki, T. and Kita, T. (1998) Circ. Res. 83, 322^327.
[10] Minami, M., Kume, N., Kataoka, H., Morimoto, M., Hayashi-
da, K., Sawamura, T., Masaki, T. and Kita, T. (2000) Biochem.
Biophys. Res. Commun. 272, 357^361.
[11] Morawietz, H., Rueckschloss, U., Niemann, B., Duerrschmidt,
N., Galle, J., Hakim, K., Zerkowski, H.R., Sawamura, T. and
Holtz, J. (1999) Circulation 100, 899^902.
[12] Li, D.Y., Zhang, Y.C., Philips, M.I., Sawamura, T. and Mehta,
J.L. (1999) Circ. Res. 84, 1043^1049.
[13] Li, D. and Mehta, J.L. (2000) Circulation 101, 2889^2895.
[14] Li, D. and Mehta, J.L. (2000) Arterioscler. Thromb. Vasc. Biol.
20, 1116^1122.
[15] Aoyama, T., Fujiwara, H., Masaki, T. and Sawamura, T. (1999)
J. Mol. Cell. Cardiol. 31, 2101^2114.
[16] Murase, T., Kume, N., Korenaga, R., Ando, J., Sawamura, T.,
Masaki, T. and Kita, T. (1998) Circ. Res. 83, 328^333.
[17] Moriwaki, H., Kume, N., Kataoka, H., Murase, T., Nishi, E.,
Sawamura, T., Masaki, T. and Kita, T. (1998) FEBS Lett. 440,
29^32.
[18] Yoshida, H., Kondratenko, N., Green, S., Steinberg, D. and
Quehenberger, O. (1998) Biochem. J. 334, 9^13.
[19] Aoyama, T., Chen, M., Fujiwara, H., Masaki, T. and Sawamura,
T. (2000) FEBS Lett. 467, 217^220.
[20] Kume, N., Moriwaki, H., Kataoka, H., Minami, M., Murase, T.,
Sawamura, T., Masaki, T. and Kita, T. (2000) Ann. N.Y. Acad.
Sci. 902, 323^327.
[21] Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Moriwaki,
H., Murase, T., Sawamura, T., Masaki, T., Hashimoto, N. and
Kita, T. (1999) Circulation 99, 3110^3117.
[22] Chen, M., Kakutani, M., Minami, M., Kataoka, H., Kume, N.,
Narumiya, S., Kita, T., Masaki, T. and Sawamura, T. (2000)
Arterioscler. Thromb. Vasc. Biol. 20, 1107^1115.
[23] Fraser, I., Hughes, D. and Gordon, S. (1993) Nature 364, 343^
346.
[24] Gowen, B.B., Borg, T.K., Gha¡ar, A. and Mayer, E.P. (2000)
Matrix Biol. 19, 61^71.
[25] el Khoury, J., Thomas, C.A., Loike, J.D., Hickman, S.E., Cao,
L. and Silverstein, S.C. (1994) J. Biol. Chem. 269, 10197^10200.
[26] Tandon, N.N., Kralisz, U. and Jamieson, G.A. (1989) J. Biol.
Chem. 264, 7576^7583.
[27] Dawson, D.W., Pearce, S.F., Zhong, R., Silverstein, R.L., Fraz-
ier, W.A. and Bouck, N.P. (1997) J. Cell. Biol. 138, 707^717.
[28] Savill, J., Hogg, N., Ren, Y. and Haslett, C. (1992) J. Clin.
Invest. 90, 1513^1522.
[29] Minami, M., Kume, N., Hayashida, K., Kataoka, H., Morimoto,
M. and Kita, T. (2000) Circulation 102, II-224.
FEBS 25180 17-8-01
T. Shimaoka et al./FEBS Letters 504 (2001) 65^6868
